Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01085760 · ClinicalTrials.gov registry record · Phase 1
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 35
- Enrollment target
NCT01085760: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT01085760 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01085760, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Vancomycin or Metronidazole is safe and beneficial in the treatment of Primary Sclerosing Cholangitis.
Interventions
- DRUG Vancomycin
- DRUG Metronidazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2010-02 |
| Est. Completion | 2011-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01085760
The ClinicalTrials.gov registry entry for NCT01085760 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vancomycin is the first listed.
NCT01085760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01085760 about?
NCT01085760 is a clinical study titled "A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis". The purpose of this study is to determine whether Vancomycin or Metronidazole is safe and beneficial in the treatment of Primary Sclerosing Cholangitis.
What is the current status of trial NCT01085760?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 35 participants. The study started on 2010-02. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01085760?
The interventions under investigation include: Vancomycin (DRUG), Metronidazole (DRUG).
Who is sponsoring clinical trial NCT01085760?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.